Vantas and implant site reaction Patient Reports February 13, 2012

Vantas Side Effects Report #4834884-X
Vantas side effect was reported by a Physician from UNITED STATES on Nov 04, 2005. Male patient, 69 years of age, was diagnosed with prostate cancer  and was treated with Vantas. After drug was administered, patient experienced the following side effects: blood testosterone increased, implant site reaction, prostatic specific antigen increased. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Patient recovered.